NASDAQ Health Care Index (IXHC) Companies by Market Cap
The NASDAQ Health Care Index (IXHC) tracks 976 constituent companies with a combined market cap of $2.62 Trillion, covering the largest publicly traded companies in USA. This ranking lists all IXHC index holdings ordered by market capitalization — from the largest index heavyweights to smaller constituents. Updated daily with live market data.
Total Market Cap (USD)
$2.62 Trillion
Constituent Companies
976
Index Country
USA
| Rank | Company | Weight (%) | Market Cap (USD) | Sector | Industry | Price | 24h Change |
|---|---|---|---|---|---|---|---|
| 51 |
Kymera Therapeutics Inc
NASDAQ:KYMR |
% | $8.99 Billion | Healthcare | Biotechnology | $112.40 | +2.84% |
| 52 |
Axsome Therapeutics Inc
NASDAQ:AXSM |
% | $8.82 Billion | Healthcare | Biotechnology | $168.35 | -1.02% |
| 53 |
10X Genomics Inc
NASDAQ:TXG |
% | $8.77 Billion | Healthcare | Health Information Services | $80.65 | +4.36% |
| 54 |
Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR |
% | $8.75 Billion | Healthcare | Biotechnology | $62.75 | +3.31% |
| 55 |
Halozyme Therapeutics Inc
NASDAQ:HALO |
% | $8.70 Billion | Healthcare | Biotechnology | $110.42 | +0.53% |
| 56 |
Cytokinetics Inc
NASDAQ:CYTK |
% | $8.62 Billion | Healthcare | Biotechnology | $62.91 | +1.45% |
| 57 |
Apogee Therapeutics, Inc. Common Stock
NASDAQ:APGE |
% | $8.40 Billion | Healthcare | Biotechnology | $135.07 | -0.01% |
| 58 |
TG Therapeutics Inc
NASDAQ:TGTX |
% | $8.37 Billion | Healthcare | Biotechnology | $55.37 | +3.81% |
| 59 |
Blueprint Medicines Corp
NASDAQ:BPMC |
% | $8.36 Billion | Healthcare | Biotechnology | $129.46 | +0.00% |
| 60 |
Twist Bioscience Corp
NASDAQ:TWST |
% | $8.26 Billion | Healthcare | Diagnostics & Research | $159.78 | +5.08% |
| 61 |
Henry Schein Inc
NASDAQ:HSIC |
% | $7.86 Billion | Healthcare | Medical Distribution | $84.01 | -0.73% |
| 62 |
Abivax SA American Depositary Shares
NASDAQ:ABVX |
% | $7.69 Billion | Healthcare | Biotechnology | $88.15 | -1.01% |
| 63 |
Ionis Pharmaceuticals Inc
NASDAQ:IONS |
% | $7.52 Billion | Healthcare | Biotechnology | $45.28 | +4.57% |
| 64 |
Spyre Therapeutics Inc.
NASDAQ:SYRE |
% | $7.44 Billion | Healthcare | Biotechnology | $85.69 | +7.25% |
| 65 |
Verona Pharma PLC ADR
NASDAQ:VRNA |
% | $7.31 Billion | Healthcare | Biotechnology | $86.00 | +0.00% |
| 66 |
Praxis Precision Medicines Inc
NASDAQ:PRAX |
% | $7.24 Billion | Healthcare | Biotechnology | $259.86 | -1.40% |
| 67 |
HealthEquity Inc
NASDAQ:HQY |
% | $7.17 Billion | Healthcare | Health Information Services | $92.61 | -0.47% |
| 68 |
Cidara Therapeutics Inc
NASDAQ:CDTX |
% | $6.96 Billion | Healthcare | Biotechnology | $221.38 | +0.03% |
| 69 |
Merus BV
NASDAQ:MRUS |
% | $6.83 Billion | Healthcare | Biotechnology | $90.00 | -7.14% |
| 70 |
Alkermes Plc
NASDAQ:ALKS |
% | $6.81 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $40.61 | +1.25% |
| 71 |
Arcellx Inc
NASDAQ:ACLX |
% | $6.73 Billion | Healthcare | Biotechnology | $115.07 | +0.00% |
| 72 |
Ligand Pharmaceuticals Incorporated
NASDAQ:LGND |
% | $6.36 Billion | Healthcare | Biotechnology | $301.81 | +2.31% |
| 73 |
Immunovant Inc
NASDAQ:IMVT |
% | $6.29 Billion | Healthcare | Biotechnology | $30.47 | +0.69% |
| 74 |
Belite Bio Inc ADR
NASDAQ:BLTE |
% | $6.17 Billion | Healthcare | Biotechnology | $164.45 | -1.77% |
| 75 |
Centessa Pharmaceuticals PLC ADR
NASDAQ:CNTA |
% | $6.10 Billion | Healthcare | Biotechnology | $39.43 | -0.10% |
| 76 |
Immunitybio Inc
NASDAQ:IBRX |
% | $5.96 Billion | Healthcare | Biotechnology | $10.51 | +6.05% |
| 77 |
Kodiak Sciences Inc
NASDAQ:KOD |
% | $5.92 Billion | Healthcare | Biotechnology | $99.87 | +5.95% |
| 78 |
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM |
% | $5.84 Billion | Healthcare | Biotechnology | $90.78 | +1.27% |
| 79 |
Bruker Corporation
NASDAQ:BRKR |
% | $5.82 Billion | Healthcare | Medical Devices | $58.84 | +1.59% |
| 80 |
Corcept Therapeutics Incorporated
NASDAQ:CORT |
% | $5.61 Billion | Healthcare | Biotechnology | $121.19 | +2.24% |
| 81 |
Erasca Inc
NASDAQ:ERAS |
% | $5.61 Billion | Healthcare | Biotechnology | $16.03 | +3.69% |
| 82 |
RadNet Inc
NASDAQ:RDNT |
% | $5.58 Billion | Healthcare | Diagnostics & Research | $70.91 | +3.96% |
| 83 |
CG Oncology, Inc. Common stock
NASDAQ:CGON |
% | $5.39 Billion | Healthcare | Biotechnology | $63.82 | +0.89% |
| 84 |
PTC Therapeutics Inc
NASDAQ:PTCT |
% | $5.37 Billion | Healthcare | Biotechnology | $64.70 | +3.42% |
| 85 |
Mirum Pharmaceuticals Inc
NASDAQ:MIRM |
% | $5.24 Billion | Healthcare | Biotechnology | $86.01 | +5.73% |
| 86 |
Merit Medical Systems Inc
NASDAQ:MMSI |
% | $5.21 Billion | Healthcare | Medical Instruments & Supplies | $87.21 | +2.30% |
| 87 |
Sotera Health Co
NASDAQ:SHC |
% | $5.15 Billion | Healthcare | Diagnostics & Research | $18.06 | +1.29% |
| 88 |
Crispr Therapeutics AG
NASDAQ:CRSP |
% | $5.15 Billion | Healthcare | Biotechnology | $53.39 | +5.85% |
| 89 |
Oruka Therapeutics, Inc.
NASDAQ:ORKA |
% | $5.12 Billion | Healthcare | Biotechnology | $82.11 | +6.25% |
| 90 |
Protagonist Therapeutics Inc
NASDAQ:PTGX |
% | $5.09 Billion | Healthcare | Biotechnology | $143.73 | +2.73% |
| 91 |
Cogent Biosciences Inc
NASDAQ:COGT |
% | $5.03 Billion | Healthcare | Biotechnology | $31.00 | +3.06% |
| 92 |
Lantheus Holdings Inc
NASDAQ:LNTH |
% | $4.93 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $100.15 | +0.03% |
| 93 |
Option Care Health Inc
NASDAQ:OPCH |
% | $4.93 Billion | Healthcare | Medical Care Facilities | $31.07 | +0.06% |
| 94 |
Travere Therapeutics Inc
NASDAQ:TVTX |
% | $4.91 Billion | Healthcare | Biotechnology | $52.13 | +0.16% |
| 95 |
Dianthus Therapeutics Inc.
NASDAQ:DNTH |
% | $4.61 Billion | Healthcare | Biotechnology | $82.37 | -0.07% |
| 96 |
Lifestance Health Group Inc
NASDAQ:LFST |
% | $4.58 Billion | Healthcare | Medical Care Facilities | $12.42 | +2.99% |
| 97 |
Waystar Holding Corp. Common Stock
NASDAQ:WAY |
% | $4.58 Billion | Healthcare | Health Information Services | $26.68 | +0.76% |
| 98 |
Amicus Therapeutics Inc
NASDAQ:FOLD |
% | $4.55 Billion | Healthcare | Biotechnology | $14.49 | +0.00% |
| 99 |
Akero Therapeutics Inc
NASDAQ:AKRO |
% | $4.50 Billion | Healthcare | Biotechnology | $54.65 | +0.00% |
| 100 |
Scholar Rock Holding Corp
NASDAQ:SRRK |
% | $4.30 Billion | Healthcare | Biotechnology | $42.19 | -0.02% |
Complete list of all companies in the IXHC index ranked by market capitalization. Track index constituent performance and market values. View all indices